Reduction of variability of exhaled nitric oxide in healthy volunteers
- PMID: 12477217
- DOI: 10.1053/rmed.2002.1390
Reduction of variability of exhaled nitric oxide in healthy volunteers
Abstract
Exhaled nitric oxide (eNO) is elevated in patients with asthma in contrast to healthy subjects, although the variability is high. In this study, we tried to reduce the variability of eNO in healthy subjects. We measured eNO using ERS guidelines with a fixed exhalation flow of 250 ml/s in 117 (72 women, 45 men) non-smoking healthy subjects and correlated this to antropometric data and standard lung function measurements. Using a model previously defined by Hyde et al., we selected parameters that were likely to have a high correlation with eNO. ENO was log-normally distributed. The normal values for eNO are significantly (P < 0.001) different for men and women: in women mean ln eNO levels (SD) were 1.49 (0.34), in men 1.74 (0.41) (back-transformed value 4.43 resp. 5.73 ppb). Using multiple regression analysis, only In D(m,CO), InTLC and In sG(aw) showed a significant positive correlation with In eNO in men, although only 20% of the variability of eNO could be explained. In women no correlation was observed and only 5% ofthe variability was explained. The high variability of eNO could only partly be explained in men, which makes the use of reference equations not very helpful.
Similar articles
-
[Concentration of nitric oxide exhaled air (eNO) in patients with COPD and bronchiectasis].Pneumonol Alergol Pol. 2003;71(9-10):418-27. Pneumonol Alergol Pol. 2003. PMID: 15052978 Polish.
-
Controlled low flow off line sampling of exhaled nitric oxide in children.Thorax. 2001 Apr;56(4):285-9. doi: 10.1136/thorax.56.4.285. Thorax. 2001. PMID: 11254819 Free PMC article.
-
Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function.Eur Respir J. 2001 May;17(5):934-8. doi: 10.1183/09031936.01.17509340. Eur Respir J. 2001. PMID: 11488329
-
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.Chest. 2003 Oct;124(4):1334-40. doi: 10.1378/chest.124.4.1334. Chest. 2003. PMID: 14555563 Clinical Trial.
-
[Exhaled nitric oxide].Allergol Immunopathol (Madr). 2000 May-Jun;28(3):124-35. Allergol Immunopathol (Madr). 2000. PMID: 10867383 Review. Spanish.
Cited by
-
Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.J Breath Res. 2008 Sep;2(3):37002. doi: 10.1088/1752-7155/2/3/037002. J Breath Res. 2008. PMID: 20664809 Free PMC article.
-
Reference values for exhaled nitric oxide (reveno) study.Respir Res. 2006 Jun 30;7(1):94. doi: 10.1186/1465-9921-7-94. Respir Res. 2006. PMID: 16813647 Free PMC article.
-
Correlation between fractional exhaled nitric oxide and Asthma Control Test score and spirometry parameters in on-treatment-asthmatics in Ho Chi Minh City.J Thorac Dis. 2020 May;12(5):2197-2209. doi: 10.21037/jtd.2020.04.01. J Thorac Dis. 2020. PMID: 32642125 Free PMC article.
-
Exhaled nitric oxide measurements: clinical application and interpretation.Thorax. 2006 Sep;61(9):817-27. doi: 10.1136/thx.2005.056093. Thorax. 2006. PMID: 16936238 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources